PBX4

Across TCGA pan-cancer cohorts, PBX4 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated PBX4 data layer compared with 25 for mass-spec protein.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher PBX4 Mutation is associated with worse disease-free survival. In most high-consensus cancer types, elevated PBX4 expression acts as an unfavorable survival marker.

KIRP and LIHC are the cancer types where PBX4 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	DFS	Median	All	0.115	0.867	<.001	24	view →
LIHC	DFS	Median	All	0.044	0.553	<.001	9	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

PBX4–KIRP (DFS)

Open the KIRP breakdown →